Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Nov, 2015 | Pages:
97 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
Global 3D bioprinting market is expected to reach USD 1.82 billion by 2022, according to a new report by Grand View Research Inc. Rising prevalence of chronic diseases such as Chronic Kidney Disease (CKD) which demands kidney transplantation is expected to boost the market growth, as 3D bioprinting is convenient and cost effective substitute for organ transplantation. Emerging medical applications of 3D bioprinting such as toxicity testing, drug discovery, tissue engineering and consumer product testing are expected to further drive the market growth positively. Increasing R&D expenditure is anticipated to be high impact rendering driver for the industry. 3D bioprinting advances in tissue engineering and allows developments to be done using biomaterials which have better biocompatibility. Moreover, rising geriatric population is expected to assist the market growth, as this demographic is highly susceptible to age related organ deformities. Further key findings from the study suggest: Syringe based printers dominated the technology segment as these printers allow working in sterile environment. Moreover, syringe based printers have wide applications which include fabrication of scaffolds, cell strips printing, and tissue printing. Magnetic levitation based printers are expected to witness lucrative growth over the forecast period. This can be attributed to emerging medical applications such as screening of cardiovascular toxicity, human cell modeling and smooth muscle printing. The medical applications segment is expected to gain substantial share of over 32.0% by 2022 which can be attributed to emerging applications of 3D bioprinting such as toxicity screening, organ transplants and medical pills. Dental application segment is expected to witness lucrative growth over the forecast period. Rising demand for cosmetic dentistry along with growing awareness about oral hygiene are expected to foster the demand for dental applications. North America dominated the regional 3D bioprinting market with over 35.0% share and is expected to grow at a CAGR of 10.0%. Supportive government initiatives to improve healthcare infrastructure coupled with growing disposable income are vital driving factor for this region's growth. Asia Pacific is expected to witness lucrative growth over the forecast period. Favorable government support to improve healthcare delivery with economic developments in emerging countries such as India and China are expected to increase the demand for 3D bioprinting. Key players operating in the 3D bioprinting industry include Organovo Holding Inc., Cyfuse Biomedical, BioBots, Luxexcel Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems, Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC, Bio3D Technologies, Solidscape and others. These players are involved in various strategic initiatives such as new product launches, strategic alliances and mergers and acquisitions to gain the edge over the competitors. For instance, In June 2015, Orgonovo collaborated with L'Oreal to develop skin tissue using NovoGen Bioprinting platform.
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. 3D Bioprinting Market- Industry Snapshot and Key Buying Criteria, 2014
Chapter 3. 3D Bioprinting Market Industry Outlook
3.1. 3D Bioprinting Market: Segmentation
3.2. 3D Bioprinting Market: Size And Growth Prospects
3.3. 3D Bioprinting Value Chain Analysis
3.4. 3D Bioprinting Market: Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.5. Key Opportunities Prioritized
3.6. Industry Analysis - Porter's
3.7. 3D Bioprinting Company Market Share, 2014
3.8. 3D Bioprinting Market: PESTEL Analysis, 2014
3.9. 3D Bioprinting Future Prospects
3.10. 3D Bioprinting Technology Overview
Chapter 4. 3D Bioprinting Market Technology Outlook
4.1. 3D Bioprinting Market Share, By Technology, 2014 & 2022
4.2. Magnetic Levitation 3D Bioprinting
4.2.1. Magnetic Levitation 3D Bioprinting Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.3. Inkjet Based 3D Bioprinting
4.3.1. Inkjet Based 3D Bioprinting Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.4. Syringe Based 3D Bioprinting
4.4.1. Syringe Based 3D Bioprinting Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.5. Laser Based 3D Bioprinting
4.5.1. Laser Based 3D Bioprinting Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.6. Others
4.6.1. Other 3D Bioprinting Market Estimates And Forecasts, 2012 - 2022 (USD Million)
Chapter 5. 3D Bioprinting Market Application Outlook
5.1. 3D Bioprinting Market Share, By Application, 2014 & 2022
5.2. Medical
5.2.1. 3D Bioprinting Medical Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.2.2. Tissue And Organ Generation
5.2.2.1. Tissue And Organ Generation Market Estimates and Forecasts, 2012 - 2022 (USD Million)
5.2.3. Medical Pills
5.2.3.1. Medical Pills Market Estimates and Forecasts, 2012 - 2022 (USD Million)
5.2.4. Prosthetics And Implants
5.2.4.1. Prosthetics And Implants Market Estimates and Forecasts, 2012 - 2022 (USD Million)
5.3. Dental
5.3.1. 3D Bioprinting Dental Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.4. Biosensors
5.4.1. 3D Bioprinting Biosensors Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.5. Consumer/Personal Product Testing
5.5.1. 3D Bioprinting Consumer/ Personal Product Testing Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.6. Bioinks
5.6.1. 3D Bioprinting Bioinks Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.7. Food And Animal Product
5.7.1. 3D Bioprinting Food And Animal Product Market Estimates And Forecasts, 2012 - 2022 (USD Million)
Chapter 6. 3D Bioprinting Market Regional Outlook
6.1. 3D Bioprinting Market Share, By Region, 2014 & 2022
6.2. North America
6.2.1. North America 3D Bioprinting Market Estimates And Forecasts, By Technology, (USD Million), 2012 - 2022
6.2.2. North America 3D Bioprinting Market Estimates And Forecasts, By Application, (USD Million), 2012 - 2022
6.3. Europe
6.3.1. Europe 3D Bioprinting Market Estimates And Forecasts, By Technology (USD Million), 2012 - 2022
6.3.2. Europe 3D Bioprinting Market Estimates And Forecasts, By Application (USD Million), 2012 - 2022
6.4. Asia Pacific
6.4.1. Asia Pacific 3D Bioprinting Market Estimates And Forecasts, By Technology (USD Million), 2012 - 2022
6.4.2. Asia Pacific 3D Bioprinting Market Estimates And Forecasts, By Application (USD Million), 2012 - 2022
6.5. Latin America
6.5.1. Latin America 3D Bioprinting Market Estimates And Forecasts, By Technology (USD Million), 2012 - 2022
6.5.2. Latin America 3D Bioprinting Market Estimates And Forecasts, By Application (USD Million), 2012 - 2022
6.6. MEA
6.6.1. MEA 3D Bioprinting Market Estimates And Forecasts, By Technology (USD Million), 2012 - 2022
6.6.2. MEA 3D Bioprinting Market Estimates And Forecasts, By Application (USD Million), 2012 - 2022
Chapter 7. Competitive Landscape
7.1. 3D Systems
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Organovo
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. CELLINK
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Envision TEC
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Materialise NV
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Bio3D Technologies
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Oceanz 3D printing & Additive Manufacturing
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Solidscape
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Stratasys Ltd.
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. Voxeljet
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
7.11. Luxexcel Group BV
7.11.1. Company Overview
7.11.2. Financial Performance
7.11.3. Product Benchmarking
7.11.4. Strategic Initiatives
7.12. TeVido BioDevices
7.12.1. Company Overview
7.12.2. Financial Performance
7.12.3. Product Benchmarking
7.12.4. Strategic Initiatives
7.13. 3Dynamics Systems
7.13.1. Company Overview
7.13.2. Financial Performance
7.13.3. Product Benchmarking
7.13.4. Strategic Initiatives
7.14. Aspect Biosystems
7.14.1. Company Overview
7.14.2. Financial Performance
7.14.3. Product Benchmarking
7.14.4. Strategic Initiatives
7.15. BioBots
7.15.1. Company Overview
7.15.2. Financial Performance
7.15.3. Product Benchmarking
7.15.4. Strategic Initiatives
7.16. Cyfuse Biomedical
7.16.1. Company Overview
7.16.2. Financial Performance
7.16.3. Product Benchmarking
7.16.4. Strategic Initiatives
List of Tables TABLE 1 3D bioprinting - Industry Snapshot & Key Buying Criteria, 2012 - 2022 TABLE 2 3D bioprinting market, by technology, 2012 - 2022 (USD Million) TABLE 3 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 4 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 5 3D bioprinting market, by region, 2012 - 2022 (USD Million) TABLE 6 3D bioprinting - Key market driver analysis TABLE 7 3D bioprinting - Key market restraint analysis TABLE 8 North America 3D bioprinting market, by region, 2012 - 2022 (USD Million) TABLE 9 North America 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 10 North America 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 11 North America 3D bioprinting medical market, by technology, 2012 - 2022 (USD Million) TABLE 12 U.S. 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 13 U.S. 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 14 U.S. 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 15 Canada 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 16 Canada 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 17 Canada 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 18 Europe 3D bioprinting market, by region, 2012 - 2022 (USD Million) TABLE 19 Europe 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 20 Europe 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 21 Europe 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 22 Germany 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 23 Germany 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 24 Germany 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 25 UK 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 26 UK 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 27 UK 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 28 Asia Pacific 3D bioprinting market, by region, 2012 - 2022 (USD Million) TABLE 29 Asia Pacific 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 30 Asia Pacific 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 31 Asia Pacific 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 32 China 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 33 China 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 34 China 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 35 Japan 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 36 Japan 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 37 Japan 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 38 Latin America 3D bioprinting market, by region, 2012 - 2022 (USD Million) TABLE 39 Latin America 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 40 Latin America 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 41 Latin America 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 42 Brazil 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 43 Brazil 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 44 Brazil 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 45 MEA 3D bioprinting market, by region, 2012 - 2022 (USD Million) TABLE 46 MEA 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 47 MEA 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 48 MEA 3D bioprinting medical market, by application, 2012 - 2022 (USD Million) TABLE 49 South Africa 3D bioprinting market, by technology 2012 - 2022 (USD Million) TABLE 50 South Africa 3D bioprinting market, by application, 2012 - 2022 (USD Million) TABLE 51 South Africa 3D bioprinting medical market, by application, 2012 - 2022 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
